Matches in SemOpenAlex for { <https://semopenalex.org/work/W2116717899> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W2116717899 endingPage "154" @default.
- W2116717899 startingPage "146" @default.
- W2116717899 abstract "Sudre P (Malaria Branch, Division of Parasitic Diseases, National Center for infectious Diseases, Centers for Disease Control, Public Health Service, US Department of Health and Human Services, Atlanta, GA 30333, USA), Breman J G, McFarland D and Koplan J P. Treatment of chloroquine-resistant malaria in African children: A cost-effectiveness analysis. International Journal of Epidemiology 1992; 21: 146–154. Because chloroquine (Cq)-resistant Plasmodium falciparum (CRPF) has now spread throughout most of Africa, the efficacy and practicability of other drugs such as amodiaquine (Aq), and pyrimethamine-suffadoxine (PS), for the treatment of fever needs to be assessed. We used a decision-analysis model to compare the cost and effectiveness of Cq. Aq, and PS. The variables considered were the probability of P. falciparum infection, drug compliance, minor and lethal side effects of the drug, the level of drug resistance in the community, and case-fatality rates associated with treatment. The measures of effectiveness were the number of malaria-related fever episodes cured parasitologically with each treatment and the number of malaria deaths prevented in children 6–59 months old. Cost-effectiveness comparisons were made for cases cured and deaths prevented. For treating 100000 febnle episodes, Cq, PS, and Aq cost US$1812, US$2622, and US$3044, respectively. Cost of the drug, compliance, and the level of CRPF had the greatest effect on the cost-effectiveness ratio. The prevalence of high-level drug resistance (RIII) was the most important deter minant of the cost-effectiveness. In a scenario with high-level CRPF, treatment with Cq costs US$0.47 to cure one patient and US$2.26 to prevent one death compared with US$0.05 and US$1.52 for treatment with PS. When the prevalence of RIII-level CRPF is greater than 14–31% (depending on the level of compliance), the most cost-effective treatment is PS, despite its 45% greater cost. Decision analysis models will be useful for malaria control planners as strategies are reconsidered in the 1990s." @default.
- W2116717899 created "2016-06-24" @default.
- W2116717899 creator A5000473081 @default.
- W2116717899 creator A5004642473 @default.
- W2116717899 creator A5017488702 @default.
- W2116717899 creator A5049181111 @default.
- W2116717899 date "1992-01-01" @default.
- W2116717899 modified "2023-10-15" @default.
- W2116717899 title "Treatment of Chioroquine-Resistant Malaria in African Children: A Cost-Effectiveness Analysis" @default.
- W2116717899 doi "https://doi.org/10.1093/ije/21.1.146" @default.
- W2116717899 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1544746" @default.
- W2116717899 hasPublicationYear "1992" @default.
- W2116717899 type Work @default.
- W2116717899 sameAs 2116717899 @default.
- W2116717899 citedByCount "54" @default.
- W2116717899 countsByYear W21167178992012 @default.
- W2116717899 countsByYear W21167178992016 @default.
- W2116717899 countsByYear W21167178992017 @default.
- W2116717899 countsByYear W21167178992021 @default.
- W2116717899 crossrefType "journal-article" @default.
- W2116717899 hasAuthorship W2116717899A5000473081 @default.
- W2116717899 hasAuthorship W2116717899A5004642473 @default.
- W2116717899 hasAuthorship W2116717899A5017488702 @default.
- W2116717899 hasAuthorship W2116717899A5049181111 @default.
- W2116717899 hasConcept C107130276 @default.
- W2116717899 hasConcept C112930515 @default.
- W2116717899 hasConcept C114851261 @default.
- W2116717899 hasConcept C126322002 @default.
- W2116717899 hasConcept C138816342 @default.
- W2116717899 hasConcept C159110408 @default.
- W2116717899 hasConcept C187316915 @default.
- W2116717899 hasConcept C203014093 @default.
- W2116717899 hasConcept C2776992834 @default.
- W2116717899 hasConcept C2777035104 @default.
- W2116717899 hasConcept C2777425658 @default.
- W2116717899 hasConcept C2778048844 @default.
- W2116717899 hasConcept C2778371730 @default.
- W2116717899 hasConcept C3019080777 @default.
- W2116717899 hasConcept C515549039 @default.
- W2116717899 hasConcept C71924100 @default.
- W2116717899 hasConcept C86803240 @default.
- W2116717899 hasConcept C89423630 @default.
- W2116717899 hasConcept C99454951 @default.
- W2116717899 hasConceptScore W2116717899C107130276 @default.
- W2116717899 hasConceptScore W2116717899C112930515 @default.
- W2116717899 hasConceptScore W2116717899C114851261 @default.
- W2116717899 hasConceptScore W2116717899C126322002 @default.
- W2116717899 hasConceptScore W2116717899C138816342 @default.
- W2116717899 hasConceptScore W2116717899C159110408 @default.
- W2116717899 hasConceptScore W2116717899C187316915 @default.
- W2116717899 hasConceptScore W2116717899C203014093 @default.
- W2116717899 hasConceptScore W2116717899C2776992834 @default.
- W2116717899 hasConceptScore W2116717899C2777035104 @default.
- W2116717899 hasConceptScore W2116717899C2777425658 @default.
- W2116717899 hasConceptScore W2116717899C2778048844 @default.
- W2116717899 hasConceptScore W2116717899C2778371730 @default.
- W2116717899 hasConceptScore W2116717899C3019080777 @default.
- W2116717899 hasConceptScore W2116717899C515549039 @default.
- W2116717899 hasConceptScore W2116717899C71924100 @default.
- W2116717899 hasConceptScore W2116717899C86803240 @default.
- W2116717899 hasConceptScore W2116717899C89423630 @default.
- W2116717899 hasConceptScore W2116717899C99454951 @default.
- W2116717899 hasIssue "1" @default.
- W2116717899 hasLocation W21167178991 @default.
- W2116717899 hasLocation W21167178992 @default.
- W2116717899 hasOpenAccess W2116717899 @default.
- W2116717899 hasPrimaryLocation W21167178991 @default.
- W2116717899 hasRelatedWork W1587738737 @default.
- W2116717899 hasRelatedWork W1848139203 @default.
- W2116717899 hasRelatedWork W2074860224 @default.
- W2116717899 hasRelatedWork W2162237038 @default.
- W2116717899 hasRelatedWork W2181430812 @default.
- W2116717899 hasRelatedWork W2402550396 @default.
- W2116717899 hasRelatedWork W2409009415 @default.
- W2116717899 hasRelatedWork W2470168894 @default.
- W2116717899 hasRelatedWork W3035397081 @default.
- W2116717899 hasRelatedWork W2406164295 @default.
- W2116717899 hasVolume "21" @default.
- W2116717899 isParatext "false" @default.
- W2116717899 isRetracted "false" @default.
- W2116717899 magId "2116717899" @default.
- W2116717899 workType "article" @default.